News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Researchers develop a new set of genetic tools designed to treat brain diseases
A consortium of researchers, including those from Seattle’s Allen Institute for Brain Science and the University of Washington, created a new molecular toolkit with potential

Seattle’s Allen Institute launches ‘moonshot’ to create new approach to cell biology research
Seattle’s Allen Institute launched a bold new initiative, CellScapes, which uses AI and mathematics to create a novel framework for understanding cellular biology. With 75

Seattle-area company VerAvanti lands $31.5M to develop scopes to prevent strokes, heart attacks
Bothell-based VerAvanti announced it has raised $31.5 million to further develop its ultra-thin imaging scopes aimed at preventing strokes and heart attacks. Founded on technology

FDA gives AI-powered blood test for obstructive CAD breakthrough device designation
Kirkland-based Prevencio has earned FDA breakthrough device designation for its HART CADhs test, an AI-powered, multi-protein blood test for detecting obstructive coronary artery disease. HART

A Day in the Life of a Pfizer Oncology Strategy Leader
Tolani Osho is driven by a powerful challenge each day: what more can we do, together with our partners, to change the future of how

Proprio receives second FDA clearance for AI platform that captures key data during surgery
Seattle-based Proprio, a startup using artificial intelligence to improve surgical precision, announced its second major clearance from the U.S. Food and Drug Administration to include

Bristol Myers to invest $40 billion in the US over 5 years
Bristol Myers Squibb recently announced it will invest $40 billion in the U.S. over the next five years to expand its research and manufacturing presence.

AGC Biologics & Novelty Nobility Partner for Cell Line Development
Headquartered in Seattle, AGC Biologics has entered a multiphase partnership with Novelty Nobility Inc., a clinical-stage biotech company based in South Korea. As part of

Microsoft’s AI for Good Lab Invests in 20 State Change-Makers
Microsoft’s AI for Good Lab has awarded $5 million over two years to 20 Washington-based organizations to help solve today’s toughest challenges through innovative, tech-driven

Spokane startup Gestalt Diagnostics raises $7.5M to advance AI-enabled cancer detection
Spokane-based startup Gestalt Diagnostics announced it has raised $7.5 million to enhance its artificial intelligence tools for digital pathology analysis. The new funding will support

Report: Washington State’s $41.2B Life Sciences Industry Grew 50% Over Past Decade
Life Science Washington, the state’s industry trade association, today released its annual Economic Impact Report, revealing a 50% increase in job growth from 2013 to

Nobel winner David Baker on moving from the ‘lunatic fringe’ to the protein design revolution
At Life Science Innovation Northwest (LSINW) 2025, Dr. David Baker, Nobel Laureate and Director of the Institute for Protein Design at the University of Washington,
